1. Home
  2. CMCO vs CLLS Comparison

CMCO vs CLLS Comparison

Compare CMCO & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$16.10

Market Cap

429.4M

Sector

Industrials

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.15

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
CLLS
Founded
1875
1999
Country
United States
France
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.4M
384.3M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
CMCO
CLLS
Price
$16.10
$4.15
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$21.00
$8.50
AVG Volume (30 Days)
444.3K
37.7K
Earning Date
05-27-2026
05-11-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
N/A
EPS
0.30
N/A
Revenue
$936,240,000.00
N/A
Revenue This Year
$19.73
N/A
Revenue Next Year
$82.91
$0.62
P/E Ratio
$53.20
N/A
Revenue Growth
3.27
N/A
52 Week Low
$12.84
$1.33
52 Week High
$24.40
$5.48

Technical Indicators

Market Signals
Indicator
CMCO
CLLS
Relative Strength Index (RSI) 54.86 66.15
Support Level $13.83 $3.25
Resistance Level $16.41 $4.46
Average True Range (ATR) 0.63 0.22
MACD 0.40 0.12
Stochastic Oscillator 89.61 76.93

Price Performance

Historical Comparison
CMCO
CLLS

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: